|
|
|
|
LEADER |
01256nam a2200265 u 4500 |
001 |
EB001839381 |
003 |
EBX01000000000000001003370 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
180702 r ||| eng |
020 |
|
|
|a 9789241550062
|
245 |
0 |
0 |
|a Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy
|h Elektronische Ressource
|
260 |
|
|
|a Geneva
|b World Health Organization
|c July 2017, 2017
|
300 |
|
|
|a 1 PDF file (x, 41 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Antiretroviral Therapy, Highly Active
|
653 |
|
|
|a Anti-HIV Agents
|
653 |
|
|
|a HIV Infections / drug therapy
|
710 |
2 |
|
|a World Health Organization
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Guideline
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK475977
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
|